Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

Ryan, Deborah; Carberry, Steven; Murphy, Áine C.; Lindner, Andreas Ulrich; Fay, Joanna; Hector, Suzanne; McCawley, Niamh; Bacon, Orna; Concannon, Caoimhín G.; Kay, Elaine; McNamara, Deborah; Prehn, Jochen

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

journal contribution

posted on 2022-11-29, 09:46 authored by Deborah Ryan, Steven Carberry, Áine C. Murphy, Andreas Ulrich Lindner, Joanna FayJoanna Fay, Suzanne Hector, Niamh McCawleyNiamh McCawley, Orna Bacon, Caoimhín G. Concannon, Elaine KayElaine Kay, Deborah McNamaraDeborah McNamara, Jochen PrehnJochen Prehn

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer.

Funding

Health Research Board. Science Foundation Ireland. European Union

History

Comments

The original article is available at www.biomedcentral.com

Published Citation

Ryan D, Carberry S, Murphy ÁC, Lindner AU, Fay J, Hector S, McCawley N, Bacon O, Concannon CG, Kay EW, McNamara DA, Prehn JH. Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer. Translational Medicine. 2016;14(1):222